Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yasuo Urata"'
Autor:
Atsushi Mukai, Yuji Yamamoto, T. Ikushima, Yasuo Urata, Chie Sotozono, Junji Hamuro, Shigeru Kinoshita, Morio Ueno
Publikováno v:
Scientific Reports
Inhibition of fibrosis is indispensable for maintaining filtering blebs after glaucoma filtration surgery (GFS). The purpose of this study was to investigate the ability of a pluripotent epigenetic regulator OBP-801 (OBP) to ameliorate extracellular
Autor:
Hiroshi Tazawa, Kiyoto Takehara, Shuya Yano, Toshiyoshi Fujiwara, Yasuo Urata, Michael Bouvet, Hiroyuki Kishimoto, Robert M. Hoffman, Shunsuke Kagawa
Publikováno v:
Anticancer Research. 36:6273-6278
Aim: Triple-negative breast cancer (TNBC), defined by the absence of receptors for estrogen, progesterone and human epithelial receptor 2 (HER2), is a recalcitrant disease in need of effective therapy. We previously isolated very-highly metastatic va
Autor:
Shuya Yano, Michael Bouvet, Kiyoto Takehara, Shinji Miwa, Robert M. Hoffman, Shunsuke Kagawa, Yasuo Urata, Hiroshi Tazawa, Toshiyoshi Fujiwara, Hiroyuki Kishimoto
Publikováno v:
Oncotarget
Oncotarget, vol 7, iss 46
Oncotarget, vol 7, iss 46
// Shuya Yano 1, 2, 3 , Kiyoto Takehara 1, 2, 3 , Shinji Miwa 1, 2 , Hiroyuki Kishimoto 3 , Hiroshi Tazawa 4 , Yasuo Urata 5 , Shunsuke Kagawa 3 , Michael Bouvet 2 , Toshiyoshi Fujiwara 3 , Robert M. Hoffman 1, 2 1 AntiCancer, Inc., San Diego, CA, US
Autor:
Hiroshi Tazawa, Yasuo Urata, Toshiyoshi Fujiwara, Michael Bouvet, Robert M. Hoffman, Shunsuke Kagawa, Kiyoto Takehara, Shuya Yano, Hiroyuki Kishimoto
Publikováno v:
Oncotarget
Our laboratory previously developed a highly-invasive, triple-negative breast cancer (TNBC) variant using serial orthotopic implantation of the human MDA-MB-231 cell line in nude mice. The isolated variant was highly-invasive in the mammary gland and
Autor:
Shunsuke Kagawa, Joe Hasei, Toshifumi Ozaki, Toshiyoshi Fujiwara, Shuhei Osaki, Tomohiro Fujiwara, Hiroshi Tazawa, Toshiyuki Kunisada, Yasuaki Yamakawa, Toshinori Omori, Aki Yoshida, Tsuyoshi Sasaki, Tadashi Komatsubara, Kazuhisa Sugiu, Yasuo Urata
Publikováno v:
Scientific Reports
Osteosarcoma is a rare disease diagnosed as malignant bone tumor. It is generally refractory to chemotherapy, which contributes to its poor prognosis. The reversal of chemoresistance is a major clinical challenge to improve the prognostic outcome of
Autor:
Kiyoto Takehara, Toshiyoshi Fujiwara, Robert M. Hoffman, Shunsuke Kagawa, Michael Bouvet, Shuya Yano, Hiroyuki Kishimoto, Yasuo Urata
Publikováno v:
Oncotarget
Malignant melanoma requires precise resection in order to avoid metastatic recurrence. We report here that the telomerase-dependent, green fluorescent protein (GFP)-containing adenovirus OBP-401 could label malignant melanoma with GFP in situ in orth
Autor:
Nobuhiro Narii, Naohiro Okada, Hiroyuki Mizuguchi, Toshiyoshi Fujiwara, Shunsuke Kagawa, Hiroshi Tazawa, Yuuri Hashimoto, Kiyoto Takehara, Hiroyuki Kishimoto, Yasuhiro Shirakawa, Satoru Kikuchi, Yasuo Urata, Shinji Kuroda
Publikováno v:
Molecular cancer therapeutics. 15(1)
Photodynamic therapy (PDT) is a minimally invasive antitumor therapy that eradicates tumor cells through a photosensitizer-mediated cytotoxic effect upon light irradiation. However, systemic administration of photosensitizer often makes it difficult